Individualized Management of Moderate-to-Severe Asthma
Saturday, February 25, 2023
8:30 PM – 9:30 PM CST Symposium
9:30 PM – 10:30 PM EST
7:30 PM – 8:30 PM MST
6:30 PM – 7:30 PM PST
Features:
- Interactive case-based learning environment
- Simulation challenge animations
- Create your own personalized poster
Learning Objectives
- Identify evidence-based strategies for treatment regimen selection or adjustments based on patient-centered factors and clinical presentation
- Describe strategies for patient-centered communication, education, and shared decision making to potentially reduce the occurrence of low adherence to treatment
- Discuss the clinical evidence for recently approved and investigational agents for the potential treatment of moderate to severe asthma
Target Audience
This activity is designed to meet the educational needs of allergists, immunologists, and other health care providers involved in the care of patients with moderate-to-severe asthma.
Accreditation Statement
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
Physician Credit Designation Statement
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
Joint Accreditation Statement
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 1.0 ANCC contact hour.
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosure Of Unlabeled Use
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact: Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at info@medlearninggroup.com
This activity is provided by Med Learning Group.
This activity is co-provided by AMEDCO.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi
Release date: February 25, 2023
Expiration date: February 25, 2024
Estimated time to completion: 1.0 hour
